• BioCardia President and CEO Peter Altman bought 5,700 common shares at a weighted-average price of $0.92.
• Altman’s direct stake rose to 291,566 shares following the purchase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCardia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-017672), on May 18, 2026, and is solely responsible for the information contained therein.